{"id":1483581,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-15","captureTimestamp":"2026-04-15T22:57:50.214000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54002.html","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) SGLT2 inhibitor use was associated with a decreased risk of serious cardiovascular events compared with the…","rawSnapshotUrl":"/api/snapshots/raw/1483581","browseUrl":"https://replay.healtharchive.ca/job-8/20260415225750/https://cihr-irsc.gc.ca/e/54002.html#ha_snapshot=1483581","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}